The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer

Giandomenico Roviello, Roberto Petrioli, Pietro Rosellini, Andrea Giovanni Multari, Raffaele Conca, Giovanni Paganini, Giorgio Chiriacò, Michele Aieta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences